Illumina Settles $9.8M False Claims Case Over Vulnerable Genomic Systems
Wednesday, 13 August 2025 ()
Illumina Inc. settled for $9.8 million under the False Claims Act, accused of selling cybersecurity-vulnerable genomic systems to federal agencies like the DOD and VA. The DOJ's Civil Cyber-Fraud Initiative case, sparked by a whistleblower, underscores data breach risks. It warns contractors to prioritize robust security standards.
|
||||
|
|
||||
You Might Like |
||||
